A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis
NCT04968275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101
Last updated 2024-05-16
Summary
Cannabis users who experienced a psychosis are particularly vulnerable to cannabis-related harms, which can include worse psychotic symptoms and more hospitalizations. Unfortunately, few psychosocial interventions exist that aim to decrease these harms. Instead, most focus on ceasing cannabis use which is rarely appealing to cannabis users. Furthermore, face-to-face psychotherapy often remains inaccessible to people with psychosis mostly due to lack of trained clinicians. Alternatives such as e-interventions have the potential to increase access to treatment and decrease clinicians' workload. Among cannabis harm reduction approaches are the protective behavioural strategies. These strategies do not encourage nor discourage cannabis use. Instead, they recommend behaviours for safer cannabis use. For example, these strategies include: 1) avoid driving a car under the influence of cannabis, 2) avoid mixing cannabis with other drugs and 3) purchase cannabis only from a trusted source. In the present pan-Canadian study, we will test the first e-intervention called CHAMPS (Cannabis Harm-reducing App for Managing Practices Safely) for cannabis harm reduction adapted for young adult cannabis users who experienced a psychosis. CHAMPS is a smartphone application that includes 17 strategies for safer cannabis use, a personalized consumption goal and a consumption journal. The goals of this study are 1) to confirm whether CHAMPS is acceptable to participants and 2) to test whether it works, notably by positively impacting participants' health and cannabis consumption habits.
Conditions
- Psychotic Disorder
- Marijuana Use
- Young Adult
Interventions
- BEHAVIORAL
-
CHAMPS
CHAMPS provides personalized feedback on participants' cannabis use behaviors and supports strategies to change such behaviors. It comprises six modules measuring the use of cannabis protective behavioural strategies, exploring the possible benefits of changing cannabis practices and setting and monitoring the reach of a SMART cannabis use goal.
Sponsors & Collaborators
-
Ministere de la Sante et des Services Sociaux
collaborator OTHER -
Centre hospitalier de l'Université de Montréal (CHUM)
lead OTHER
Principal Investigators
-
Didier Jutras-Aswad, MD, MSc · Centre hospitalier de l'Université de Montréal (CHUM)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-23
- Primary Completion
- 2023-09-30
- Completion
- 2023-10-24
Countries
- Canada
Study Locations
More Related Trials
-
MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva
NCT05432206 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
NCT05445180 ·Status: RECRUITING ·Phase: NA
-
Stratification and Treatment in Early Psychosis Study - ENHANCE
NCT06778564 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Using Short Message Service as a Means of Clinical Engagement in Early Psychosis
NCT04379349 ·Status: COMPLETED ·Phase: NA
-
Contrasting Group Therapy Methods for Psychosis
NCT01764568 ·Status: TERMINATED ·Phase: NA
-
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
NCT06225232 ·Status: RECRUITING ·Phase: PHASE2
-
Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia
NCT01382433 ·Status: UNKNOWN ·Phase: NA
-
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
NCT04298450 ·Status: COMPLETED ·Phase: NA
-
Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study
NCT07309159 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions
NCT00358709 ·Status: COMPLETED ·Phase: PHASE3
-
Probing the Cannabinoid System in Individuals With a Family History of Psychosis
NCT02102113 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis
NCT01565174 ·Status: UNKNOWN
-
Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse
NCT00798109 ·Status: COMPLETED ·Phase: NA
-
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
NCT01964404 ·Status: COMPLETED ·Phase: PHASE1
-
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study
NCT04605393 ·Status: COMPLETED ·Phase: NA
-
COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSE
NCT02319746 ·Status: COMPLETED ·Phase: NA
-
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
NCT03883360 ·Status: WITHDRAWN ·Phase: PHASE2
-
Action-based Cognitive Remediation for First Episode Psychosis
NCT03814122 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol Treatment in Patients With Early Psychosis
NCT02504151 ·Status: COMPLETED ·Phase: PHASE2
-
mHealth for Psychosis Help-seeking
NCT05905601 ·Status: COMPLETED ·Phase: NA
-
Youth Experiences and Health Study
NCT03332966 ·Status: RECRUITING
-
Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis
NCT05686772 ·Status: COMPLETED
-
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
NCT00946348 ·Status: COMPLETED ·Phase: PHASE1
-
Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosis (FEP)
NCT07245212 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
NCT01832766 ·Status: TERMINATED ·Phase: PHASE1/PHASE2